Mice Model Market (2023-2030)

The Mice Model Market is projected to reach $2.48 billion by 2030, at a CAGR of 6.5% from 2023 to 2030.

Published
May 2023
Pages
180
Format
PDF + Excel
Report ID
MRHC - 10440
Base year
2022
Market size · USD billion · 2022–2030Forecast 2023–2030 · 6.5% CAGR
2030 · FORECAST
$2.48B
2030
$2.48B
CAGR 2023–2030
6.5%
$3B$2.25B$1.5B$750M0
2022
2023
'24
'25
'26
'27
'28
'29
'30

2022 baseline · 2023–2030 forecast at 6.5% CAGR · hover a bar for the value

Key highlights

01

In 2023, the Inbred Mice Segment is Expected to Dominate the Mice Model Market

02

In 2023, the Breeding Segment is Expected to Dominate the Mice Model Market

03

In 2023, the CRISPR/CAS9 Segment is Expected to Dominate the Mice Model Market

04

In 2023, the Outsourced Segment is Expected to Dominate the Mice Model Market

05

In 2023, the Oncology Studies Segment is Expected to Dominate the Mice Model Market

06

In 2023, the Pharmaceutical & Biotechnology Companies Segment is Expected to Dominate the Mice Model Market

07

Asia-Pacific: The Fastest-growing Regional Market

Report summary

ParticularsDetails
Base Year2022
Estimated Year2023
Forecast Period2023–2030
Market Size (2030)USD 2.48 billion
CAGR (2023–2030)6.5%
FormatPDF, Excel & Cloud Portal · 180 pages
Segments CoveredBy Mice Type: Inbred Mice, Genetically Engineered Mice, Outbred Mice, Hybrid/Congenic Mice, Conditioned/Surgically Modified Mice, Spontaneous Mutant Mice, Other Types · By Service: Breeding, Cryopreservation, Model-in Licensing, Genetic Testing, Quarantine, Other Services · By Technology: CRISPR/CAS9, Embryonic Stem Cell Injection, Nuclear Transfer, Other Technologies · By Mode: Outsourced, In-house · By Application: Oncology Studies, Cardiovascular Studies, Genetic Studies, Endocrine Metabolic Studies, Neurological Studies, Immunology & Inflammation studies, Other Applications · By End User: Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Contract Research Organizations, Other End Users
Countries CoveredLatin America (RoLATAM)
Key CompaniesCharles River Laboratories International, Inc. (U.S.), Jackson Laboratory (U.S.), Laboratory Corporation of America Holdings (U.S.), Horizon Discovery Group plc (U.K.), Trans Genic Inc., GenOway S.A., Taconic Biosciences, Inc.(U.S.), Envigo Ltd (U.S.), Janvier Labs, Crescendo Biologics Ltd. (U.K.), Deltagen Inc. (U.S.), ImmunoGenes Kft

Report overview

Scope note

Segments covered: mice type, service, technology, mode, application, end user. Regions: Latin America.

Mice models are commonly used for studying aspects of human health & diseases. Mice are especially useful for this purpose since they have similar mammalian features to that of humans. There are different types of mice models, such as inbred mice, genetically engineered mice, hybrid/congenic mice, and conditioned/surgically modified mice. These models can be used for various applications, such as oncology, cardiology, genetic, and endocrine and metabolic studies.

The growth of this market is driven by factors such as the advantages of mice as an animal model for studying human diseases, the rising prevalence of cancer, the increasing number of grants for research studies, and the rising demand for personalized medicine. In addition, the technological advancements & innovations in mice models are expected to provide significant growth opportunities for this market.

However, ethical concerns and regulatory restrictions are expected to hinder the growth of this market to a certain extent. In addition, factors such as the lack of skilled personnel for performing animal studies and the high cost of mice models are the major challenges to the growth of this market.

Report infographic

Mice Model Market
Mice Model Market · Report infographic

Market dynamics

1 factors across 1 force
01

Increasing Prevalence of Cancer to Drive Demand for Mice Models in Cancer Research

Cancer has been one of the most complex and expensive diseases globally, with a huge economic burden on many countries. The International Agency for Research on Cancer (IARC) estimates that globally, 1 in 5 people develop cancer during their lifetimes, with 1 in 8 men and 1 in 11 women dying from the disease.

Cancer is a major cause of death and a prominent obstacle to improving life expectancy in every country worldwide. According to the International Agency for Research on Cancer (IARC), the number of new cancer cases is expected to reach 24.5 million by 2030. In addition, mortalities from cancer are expected to increase from 9.9 million in 2020 to 12.9 million by 2030.

Mice models can be used to identify the genetic causes of cancer, reproduce tumor types in mice and test new cancer therapies. Thus, the increasing prevalence of cancer is driving the use of mice models in cancer research.

Table of contents

14 chapters · 112 sections · 180 pages · click to expand
Review the full research scope before you buy. Chapters can also be purchased individually.

1.1Market Definition
1.2Market Ecosystem
1.3Currency
1.4Key Stakeholders

Segmental analysis

SegmentLargest share (2023)Fastest growth (2023–2030)
By Mice TypeInbred Mice—
By ServiceBreeding—
By TechnologyCRISPR/CAS9—
By ModeOutsourced—
By ApplicationOncology Studies—
By End UserPharmaceutical & Biotechnology Companies—
01

By Mice Type

  • The inbred mice segment is expected to account for the largest share of the mice model market.
  • Inbred mice are colonies produced by mating twenty or more generations of brother-sister pairs.
  • This mating provides mice that are genetically identical within each inbred strain.
  • The large market share of this segment is attributed to the increased use of inbred mice due to their advantages, such as unique and stable phenotypic traits, consistency in the test results, and predictable experiment response.
CoversInbred MiceGenetically Engineered MiceOutbred MiceHybrid/Congenic MiceConditioned/Surgically Modified MiceSpontaneous Mutant MiceOther Types
02

By Service

  • The breeding segment is expected to account for the largest share of the mice model market.
  • The large market share of this segment is attributed to the increased demand for breeding services for providing genetically modified mice strains, the increasing number of research projects and research funding.
CoversBreedingCryopreservationModel-in LicensingGenetic TestingQuarantineOther Services
03

By Technology

  • The CRISPR/CAS9 segment is expected to account for the largest share of the mice model market.
  • The large market share of this segment is attributed to the advantages of using this technology in genome editing for creating unique mouse models of human disease.
  • This technology can produce mice models in a cost-effective way while saving time and potentially reducing the number of animal usage.
CoversCRISPR/CAS9Embryonic Stem Cell InjectionNuclear TransferOther Technologies
04

By Mode

  • The outsourced segment is expected to account for the larger share of the mice model market.
  • The large market share of this segment is attributed to the advantages of outsourcing mice models, such as cost savings, increased flexibility, access to specialized expertise, and availability of a large variety of models.
CoversOutsourcedIn-house
05

By Application

  • The oncology studies segment is expected to account for the largest share of the mice model market.
  • The large market share of this segment is attributed to the increased prevalence of cancer, increased funding for cancer research, and advantages of using mice models in cancer research, such as the ability to physiologically imitate cancer as humans.
CoversOncology StudiesCardiovascular StudiesGenetic StudiesEndocrine Metabolic StudiesNeurological StudiesImmunology & Inflammation studiesOther Applications
06

By End User

  • The pharmaceutical & biotechnology companies segment is expected to account for the largest share of the mice model market.
  • The large market share of this segment is attributed to the increased global pharmaceutical R&D expenditure, rising demand for personalized medicine, and a large number of therapeutic drug molecules in the research pipeline.
CoversPharmaceutical & Biotechnology CompaniesAcademic & Research InstitutesContract Research OrganizationsOther End Users

Geographic analysis

01

Asia-Pacific

Fastest growth

Asia-Pacific is slated to record the highest CAGR in the mice model market during the forecast period. The growth of this market is driven by the rapidly growing pharmaceutical & biotechnology industry in the region, increasing R&D expenditure, and increasing government funding for research projects, especially in China and India. Asia-Pacific: The Fastest-growing Regional Market

Competitive landscape

Companies profiled (13)
  • Charles River Laboratories International, Inc. (U.S.)
  • Jackson Laboratory (U.S.)
  • Laboratory Corporation of America Holdings (U.S.)
  • Horizon Discovery Group plc (U.K.)
  • Trans Genic Inc. · Japan
  • GenOway S.A. · France
  • Taconic Biosciences
  • Inc.(U.S.)
  • Envigo Ltd (U.S.)
  • Janvier Labs · France
  • Crescendo Biologics Ltd. (U.K.)
  • Deltagen Inc. (U.S.)
  • ImmunoGenes Kft · Hungary

Frequently asked questions

This market study covers the market sizes & forecasts of the mice model market based on mice type, services technology, mode, application, end user, and geography. This market study also provides the value analysis of various segments and subsegments of the mice model market at the regional and country levels.

Cite this report

Meticulous Research. (2023). Mice Model Market - Global Opportunity Analysis and Industry Forecast (2023-2030) (Report No. MRHC - 10440). Meticulous Market Research Pvt. Ltd. https://www.meticulousresearch.com/product/mice-model-market-4151

Search Market Intelligence

Search across reports, blogs, press releases, and industries